PAR 2.50% 20.5¢ paradigm biopharmaceuticals limited..

New orphan drug designation, page-46

  1. 4,356 Posts.
    lightbulb Created with Sketch. 6905
    Amazing...again to read these scientific journals and evidence is something but how amazing is it to SEE the results!

    Geepers, what do we have here ... it's going to bring such relief to patients, maybe it doesn't translate (like we see in the videos above) 100% into humans but the evidence so far at least in terms of joint pain is startling. How good will it be when we start getting real data back on a larger set of MPS patients ...


    Thanks Gan Gans

 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.